ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EVG Evgen Pharma Plc

0.80
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 422k -4.04M -0.0147 -0.54 2.2M
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.80p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 4.05p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.20 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.54.

Evgen Pharma Share Discussion Threads

Showing 9951 to 9973 of 13025 messages
Chat Pages: Latest  401  400  399  398  397  396  395  394  393  392  391  390  Older
DateSubjectAuthorDiscuss
31/3/2022
09:38
What's Evgen Pharam?
on target
31/3/2022
09:26
New thread for discussion on Evgen Pharam. I will be updating the thread over today. The share price has fallen from placing price of 8p to 3.5p. Adequate cash to last 2-3 years and an updated website and presentation. Drugs in development include SFX-01 and others.
manual dexterity
31/3/2022
09:20
Starting a new thread. for 2022.
manual dexterity
31/3/2022
09:18
closed thread.
manual dexterity
29/3/2022
13:43
From the Presentation :

Recent Achievements

mBC Commencement of pre-clinical collaboration with the University of
Manchester and The Christie Hospital. Generate data to optimise
positioning of SFX-01 in breast cancer treatment following promising
Phase 2a clinical data.

Out license market average $19m up front, $144m total, 10-14%
royalty*

Glioma Publication of powerful pre-clinical data including significant survival
benefit, October 2021
Out licence market average $11m up front, $90m total, 8-12%
royalty*

Onc 3 Collaboration underway with a prestigious academic institution on a
target relevant to solid tumours and blood cancers.
Partner Sulforadex technology licence concluded with Juvenescence for nonpharmaceutical applications using naturally derived sulforaphane.

$10.5m in milestones / options plus royalty. Market launch in 2023
FDA Orphan Drug designation achieved with FDA for malignant glioma,
September 2021.
* Source Global Data, Pre-clinical to Phase2 only, disclosed deal

manual dexterity
29/3/2022
08:53
Thanks for posting that link MD.
clocktower
29/3/2022
07:57
To add further, James Robert Kight is the largest shareholder and has constantly added to 12% and may go beyond. So I would not be surprised to see him add at all time lows.
manual dexterity
29/3/2022
07:49
Yesterday's trade could be the end of the overhang. Certainly online limits have been slashed and cash available should last at least another 2 / 3 years.

UPDATE PRESENTATION

manual dexterity
28/3/2022
13:51
Good to see some decent volume anyway. Still cannot understand who was selling all those shares of late, without any TR-1's to follow. Surely not just PI's packing up and leaving?
Ah well, wake me up if/when we revisit the 9p region. GLA.

lovewinshatelosses
28/3/2022
12:52
Wonder if that 5M is from Juv-life? That would put a cat among the pigeons.
We won't get a TR-1 just from that though as it's 'only' 1.8%.

on target
28/3/2022
11:09
Any overhang there was has clearly been shifted and its not long before it will be back to 5p and if we get get more positive news the sky will be very blue.
clocktower
28/3/2022
10:35
Somethings cooking with that 5mmn trade and volume way this morning.
clocktower
24/3/2022
22:30
another one for the AIM 1p club......
theonewhoknows2
24/3/2022
21:29
Presumably it is now at a level where cash and assets (excluding the directors) exceeds liabilities ( including directors) substantially.
bocker01
24/3/2022
10:20
Walbrook and fincap say no more !!!
amaretto1
24/3/2022
10:07
worked sale of 800000 gone through at 3p, ouch. Hopefully this has been dragging price a bit and can move forward now...some news would be good.
markth126
23/3/2022
08:00
Yep. Some decent inside buying (like 4D BOD did) should have been the minimum criteria to consider investing here as a PI...but I am a LTH and frankly did not apply the same criteria to my AIM investment strategy then as I do now.
All that said, I still think we might have something worthwhile here, so I remain a holder - but not a happy one right now - unlike 4D at the time of print :)

lovewinshatelosses
22/3/2022
08:33
Management want shooting....Total mkt destruction of a company value wise ....They came to mkt and fleeced share holders .... backed up with a ramp bridge working for their house broker.The red flag was NO monetary commitment by them !! Some one change my mind on these crooks ....
amaretto1
21/3/2022
13:43
Really turning out to be a dog with not an owner wanting it, as the slid continues.
clocktower
11/3/2022
16:21
Not before time either. So oversold it was only a matter of time before we would see the start of a decent bounce.
clocktower
11/3/2022
15:55
A few buyers this afternoon..
on target
07/3/2022
16:38
Such an expert !!The rats have left ......
amaretto1
07/3/2022
14:14
Going by past performance, this announcement will just be the start of it. Expect more over the next week. Don't hold your breath though, they'll just regurgitate what's out there already but with added sparkle.
kingalf
Chat Pages: Latest  401  400  399  398  397  396  395  394  393  392  391  390  Older

Your Recent History

Delayed Upgrade Clock